Société de Therapeutique Marocaine S.A.

CBSE:SOT Stok Raporu

Piyasa değeri: د.م6.8b

Société de Therapeutique Marocaine Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Société de Therapeutique Marocaine has been growing earnings at an average annual rate of 6.3%, while the Pharmaceuticals industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 10.1% per year. Société de Therapeutique Marocaine's return on equity is 18.2%, and it has net margins of 10.7%.

Anahtar bilgiler

6.3%

Kazanç büyüme oranı

5.8%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi12.4%
Gelir büyüme oranı10.1%
Özkaynak getirisi18.2%
Net Marj10.7%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Société de Therapeutique Marocaine nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

CBSE:SOT Gelir, gider ve kazançlar (MAD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 242,6302816820
31 Mar 242,5582726830
31 Dec 232,4862636830
30 Sep 232,4112626570
30 Jun 232,3362606380
31 Mar 232,3192646210
31 Dec 222,3022676050
30 Sep 222,2682865880
30 Jun 222,2333065720
31 Mar 222,1452935570
31 Dec 212,0562795420
30 Sep 211,9982645280
30 Jun 211,9402495130
31 Mar 211,8692404920
31 Dec 201,7982304710
30 Sep 201,7372334480
30 Jun 201,6752354240
31 Mar 201,6802274400
31 Dec 191,6862204560
30 Sep 191,6471734300
30 Jun 191,6671964810
31 Mar 191,6292074710
31 Dec 181,5611824230
30 Sep 181,5442084530
30 Jun 181,4971984440
31 Mar 181,4561744360
31 Dec 171,4151504290
30 Sep 171,4001534170
30 Jun 171,3861554050
31 Mar 171,3561523970
31 Dec 161,3261493900
30 Sep 161,2611353860
30 Jun 161,1951213830
31 Mar 161,1751193790
31 Dec 151,1561183750
30 Sep 151,1551153700
30 Jun 151,1551133660
31 Mar 151,1381023600
31 Dec 141,122923540
30 Sep 141,125953530
30 Jun 141,129973510
31 Mar 141,1241073450
31 Dec 131,1191173380

Kaliteli Kazançlar: SOT has high quality earnings.

Büyüyen Kar Marjı: SOT's current net profit margins (10.7%) are lower than last year (11.1%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: SOT's earnings have grown by 6.3% per year over the past 5 years.

Büyüme Hızlandırma: SOT's earnings growth over the past year (7.7%) exceeds its 5-year average (6.3% per year).

Kazançlar vs. Sektör: SOT earnings growth over the past year (7.7%) did not outperform the Pharmaceuticals industry 16%.

Özkaynak Getirisi

Yüksek ROE: SOT's Return on Equity (18.2%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y